MUC5B and interstitial lung disease: Furthermore, we investigated the influence of recipient MUC5B polymorphism on post-transplant incidence of chronic lung allograft dysfunction (CLAD) and graft loss in the ILD population and the entire population of patients who underwent lung transplantation for a chronic end-stage respiratory disease between 2004 and 2015.